A SARS-CoV-2 antibody retains potent neutralization against Omicron by targeting conserved RBM residues.
Chunyan YiZhiyang LingXiao LuYadong FuZhuo YangSonam WangmoShuangfeng ChenYaguang ZhangLiyan MaWangpeng GuHongzhou LuXiaoyu SunBing SunPublished in: Cellular & molecular immunology (2022)